ClinicalTrialsFinder

Esophageal Cancer Clinical Trials in Nagoya, Aichi-ken

2 recruitingNagoya, Aichi-ken, Japan

Showing 1–2 of 2 trials

Recruiting
Phase 1

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or Bevacizumab

Triple-Negative Breast CancerPancreatic CancerNon-small Cell Lung Cancer+4 more
AbbVie512 enrolled35 locationsNCT05005403
Recruiting

Predicting Early Tumor Recurrence in Patients With Esophageal Squamous Cell Carcinoma

Esophageal CancerRecurrenceDNA Methylation
City of Hope Medical Center150 enrolled2 locationsNCT06476067